Global surveillance of cancer survival
The CONCORD programme at the London School of Hygiene & Tropical Medicine comprises epidemiological research, teaching and capacity-building in global surveillance of cancer survival. CONCORD is supported by the Union for International Cancer Control (UICC) as a programme of strategic significance for the World Cancer Declaration.
Participants in the CONCORD-2 study can access CONCORD here. Please keep the email with your user name and password, so that you can access the documents as needed.
CONCORD will contribute to the WHO Action Plan for non-communicable diseases, by promoting international partnerships to evaluate the effectiveness of cancer control at national, regional and global levels.
The CONCORD-2 study will examine global trends and geographic differences in survival for 10 cancers in adults, and childhood leukaemia. It will include patients diagnosed during the period 1995-2009 or later. More than 290 cancer registries in 72 countries have signed up to participate, and so far, 265 have submitted data. Estimates should be available for 33 low- and middle-income countries: 9 in Africa, 8 out of 9 participating countries in Central and South America, 10 of 19 in Asia and 6 of the 24 in Europe. About half the countries will contribute data with 100% coverage of the national population.
The CONCORD Working Group met on 20-21 September 2012 in Cork, Ireland, after the IACR 2012 Conference. The agenda and presentations are available.
The CONCORD Steering Committee includes 26 scientists and 2 cancer patients from 16 countries, with expertise in biostatistics, epidemiology, cancer registration and public health. The Steering Committee met to review progress and consider plans for 2014 in Buenos Aires, Argentina, on 24 October 2013, shortly after the 35th Scientific Conference of the International Association of Cancer Registries.
The CONCORD programme is currently funded by nine agencies in five countries, to the end of 2016. The programme is endorsed by 31 national and international agencies, including WHO EURO, the Organisation for Economic Co-operation and Development (OECD) and the World Bank.
A number of agencies have agreed to provide funding for CONCORD:
- Canadian Partnership Against Cancer (Toronto), two years 2013-14
- Cancer Focus Northern Ireland (Belfast), researcher seconded to London 2013-14
- Cancer Institute New South Wales (Sydney), two researchers
- Cancer Research UK (London), four years 2013-16
- Centers for Disease Control and Prevention (Atlanta), three years 2012-15
- Children with Cancer UK (London), PhD student 2013-15
- Swiss Re (London), two years 2012-14
- Swiss Cancer Research foundation (Bern), three years 2013-16
- Swiss Cancer League (Bern), three years 2013-16
The 9th edition of our annual short course “Cancer survival: principles, methods and applications” will be held at the School from 30 June to 4 July 2014.